Download PDF
1 / Pages

Other users also viewed these articles

Economic impact of the use of patiromer in chronic kidney disease or heart failure for the treatment of chronic hyperkalemia in Spain Patricia de Sequera; Ramón Bover; Yoana Ivanova-Markova; Alexandra Ivanova; Almudena González-Domínguez; Marta Valls; Verónica Campos;
Nefrologia (English Version). 2023;43:721-30
Cost-effectiveness of sodium zirconium cyclosilicate for the treatment of hyperkalemia in patients with chronic kidney disease or heart failure in Spain Roberto Alcázar-Arroyo; María G Crespo-Leiro; Jordi Bover; Juan Oliva; Miren Sequera-Mutiozabal; Simona Gradari; Anisia Martínez-López; Blanca López-Chicheri; Neus Vidal-Vilar; Susana Aceituno; Marta Cobo;
10.1016/j.nefroe.2024.10.001
New approaches in the nutritional treatment of advanced chronic kidney disease María Martínez-Villaescusa; Ángel Aguado-García; Aurora López-Montes; Mercedes Martínez-Díaz; César Gonzalvo-Díaz; Ana Pérez-Rodriguez; Asunción Pedrón-Megías; Llanos García-Arce; Paloma Sánchez-Sáez; Clara García-Martínez; Abígail Azaña-Rodríguez; Ana Belén García-Martínez; Fernando Andrés-Pretel; Francisco Botella-Romero; Almudena Vega-Martínez; José Miguel Giménez Bachs; Miguel León-Sanz;
Nefrologia (English Version). 2022;42:448-59